Carsten Hamann is a Dermatology physician affiliated with Dartmouth–Hitchcock Medical Center. OpenAlex indexes 91 publications with 2,395 citations (h-index 28).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 E Mcdowell Rd
Phoenix, AZ 850083884
Telephone
480-681-3300Provider last certified this registry record 29 Dec 2025.
Industry payments
42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year202559 payments$91,011openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year202540 payments$88,210openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year202522 payments$27,728openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
89.5%Porphyrin Precursor88.3%Aminolevulinic acid hcl100%Part B, office-administered≥21 patientsNucleoside Metabolic Inhibitor1.1%Fluorouracil100%Part D≥56 patientsDermatology
4.2%Corticosteroid4%Triamcinolone Acetonide100%Part D≥140 patientsAntivirals0.2%Imiquimod100%Part D<11 patientsAnti-infectives
3.2%Azole Antifungal1.9%Ketoconazole100%Part D≥61 patientsTetracycline-class Drug0.8%Doxycycline Hyclate61%Doxycycline Monohydrate39%Part D≥24 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparison of staged excision and Mohs micrographic surgery with and without MART-1 immunostains for surgical treatment of melanoma of the head, neck, and special sites: A retrospective cohort study
Journal of the American Academy of Dermatology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Kenneth Meehan, MD
Dartmouth–Hitchcock Medical Center
Thamolwan Surakiatchanukul, MD
Dartmouth–Hitchcock Medical Center
Payam Moein, MD
Dartmouth–Hitchcock Medical Center
Linda Vahdat, MD
Dartmouth–Hitchcock Medical Center
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”